ArticleScientific reports2025
Identification of immune phenotypes and diagnostic biomarkers in active and latent tuberculosis infections.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Generalized linear modeling of flow cytometry data to analyze immune responses in tuberculosis vaccine research.NPJ systems biology and applications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The diagnosis and treatment of tuberculosis rely on a deep understanding of the pathobiology and immune responses. This study aimed to identify potential immune response mechanisms by integrating gene expression analysis with immune cell distribution profiling to characterize the immune phenotypes of active tuberculosis (ATB) and latent tuberculosis infection (LTB). Differentially expressed genes (DEGs) between ATB or LTB and controls were identified using the GSE19491 and GSE107994 datasets. A total of 273 and 105 immune-related DEGs were identified in ATB and LTB through ImmProt database, respectively. Immune-related DEGs specific to LTB were mainly enriched in the MAPK signaling pathway, Ras signaling pathway. Furthermore, random forest analysis identified HLA-DRB5 and IRF1 as showing diagnostic potential in ATB, LCN10, SHC1, IKBKG, RETN, and SOS1 showed importance in LTB. Flow cytometry detected significantly higher levels of macrophages M0 in ATB compared to LTB and controls, while other types of immune cells showed significant increases in LTB. The levels of marker genes were validated by RT-qPCR and Western blot, as well as single-cell data in ATB and LTB. The findings of this study provide potential biomarkers for the diagnosis of tuberculosis and may facilitate the development of more effective treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.